Update on kidney transplantation for the urologist.
The incidence of end-stage renal disease (ESRD) in the United States is increasing dramatically and renal transplantation is the best treatment for many of these patients. The results of kidney transplantation also have improved. This has resulted in a significant demand for organs that is not met by the current supply of deceased donors. There now are more living kidney donors than cadaveric donors because the results of living donor renal transplantation are superior and the prolonged wait for a cadaveric kidney transplant can be avoided. Therefore, urologists will have increasing exposure to patients with ESRD and those with renal transplantation.
Gritsch
H Albin
HA
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-1738, USA. hgritsch@mednet.ucla.edu
D005260:Female; D005544:Forecasting; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000592:standards / Q000639:trends*; D019520:Living Donors; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000592:standards / Q000639:trends*; D016896:Treatment Outcome; D014481:United States; D014572:Urology / Q000592:standards / Q000639:trends